BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9261415)

  • 1. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.
    Nonkwelo C; Ruf IK; Sample J
    J Virol; 1997 Sep; 71(9):6887-97. PubMed ID: 9261415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
    Schaefer BC; Paulson E; Strominger JL; Speck SH
    Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency.
    Zhang L; Pagano JS
    Mol Cell Biol; 1997 Oct; 17(10):5748-57. PubMed ID: 9315633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.
    Nonkwelo C; Ruf IK; Sample J
    J Virol; 1997 Jan; 71(1):354-61. PubMed ID: 8985357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.
    Zhang L; Pagano JS
    Mol Cell Biol; 1999 Apr; 19(4):3216-23. PubMed ID: 10082588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
    Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency.
    Ruf IK; Sample J
    J Virol; 1999 Oct; 73(10):7943-51. PubMed ID: 10482541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
    Nonkwelo C; Skinner J; Bell A; Rickinson A; Sample J
    J Virol; 1996 Jan; 70(1):623-7. PubMed ID: 8523583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Schaefer BC; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
    Yoshioka M; Crum MM; Sample JT
    J Virol; 2008 Feb; 82(4):1679-87. PubMed ID: 18077719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription of Epstein-Barr virus-encoded nuclear antigen 1 promoter Qp is repressed by transforming growth factor-beta via Smad4 binding element in human BL cells.
    Liang CL; Tsai CN; Chung PJ; Chen JL; Sun CM; Chen RH; Hong JH; Chang YS
    Virology; 2000 Nov; 277(1):184-92. PubMed ID: 11062049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Epstein-Barr virus Fp promoter.
    Nonkwelo C; Henson EB; Sample J
    Virology; 1995 Jan; 206(1):183-95. PubMed ID: 7831773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
    Sample J; Brooks L; Sample C; Young L; Rowe M; Gregory C; Rickinson A; Kieff E
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6343-7. PubMed ID: 1648738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
    Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene.
    Tsai CN; Liu ST; Chang YS
    DNA Cell Biol; 1995 Sep; 14(9):767-76. PubMed ID: 7669254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
    J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
    Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
    J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.